Clinical trials: Vascular Endothelial Function

Metabolic Syndrome

The Impact of Free Fatty Acid Reduction on Vascular Function in the Metabolic Syndrome

• Completed
• Age: 18 years and older
• Phase 2/3
• Results posted

This study will test the hypothesis that reducing the release of free fatty acids (FFA) from fat cells will restore insulin-mediated, endothelium-dependent vasodilation in people with the metabolic syndrome.

Trial name

NCT00759291

Testing

acipimox

Where

United States

Volunteers

40 people, healthy volunteers welcome

Sponsor

Brigham and Women's Hospital